Akero Therapeutics, Inc. (AKRO)
USD 37.13
(-7.15%)
USD 37.13
(-7.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -208.16 Million USD | 12.84% |
| 2022 | -238.82 Million USD | -60.32% |
| 2021 | -148.96 Million USD | 19.66% |
| 2020 | -185.43 Million USD | -35.95% |
| 2019 | -136.4 Million USD | -79.53% |
| 2018 | -75.97 Million USD | -12604.85% |
| 2017 | -598 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -587.66 Million USD | -182.31% |
| 2024 Q2 | -274.08 Million USD | 53.36% |
| 2023 Q1 | -231.84 Million USD | 2.93% |
| 2023 Q4 | -208.16 Million USD | 14.44% |
| 2023 Q2 | -417.98 Million USD | -80.29% |
| 2023 FY | -208.16 Million USD | 12.84% |
| 2023 Q3 | -243.3 Million USD | 41.79% |
| 2022 Q2 | -166.9 Million USD | -12.0% |
| 2022 FY | -238.82 Million USD | -60.32% |
| 2022 Q4 | -238.82 Million USD | 34.23% |
| 2022 Q3 | -363.11 Million USD | -117.55% |
| 2022 Q1 | -149.02 Million USD | -0.04% |
| 2021 Q1 | -186.15 Million USD | -0.39% |
| 2021 Q3 | -163.37 Million USD | -4.8% |
| 2021 Q2 | -155.89 Million USD | 16.26% |
| 2021 Q4 | -148.96 Million USD | 8.82% |
| 2021 FY | -148.96 Million USD | 19.66% |
| 2020 Q2 | -63.24 Million USD | -34.53% |
| 2020 FY | -185.43 Million USD | -35.95% |
| 2020 Q4 | -185.43 Million USD | 2.82% |
| 2020 Q3 | -190.81 Million USD | -201.69% |
| 2020 Q1 | -47.01 Million USD | 65.51% |
| 2019 Q3 | -147.83 Million USD | 9.11% |
| 2019 Q1 | -69.79 Million USD | 8.13% |
| 2019 Q2 | -162.65 Million USD | -133.04% |
| 2019 FY | -136.4 Million USD | -79.53% |
| 2019 Q4 | -136.31 Million USD | 7.79% |
| 2018 Q3 | -7.83 Million USD | 0.0% |
| 2018 FY | -75.97 Million USD | -12604.85% |
| 2018 Q4 | -75.97 Million USD | -870.06% |
| 2018 Q1 | 598 Thousand USD | 200.0% |
| 2017 FY | -598 Thousand USD | 0.0% |
| 2017 Q4 | -598 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -272.12% |
| Alkermes plc | -166.73 Million USD | -24.844% |
| Agenus Inc. | 274.13 Million USD | 175.935% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 111.132% |
| Aptorum Group Limited | 1.35 Million USD | 15439.495% |
| Ardelyx, Inc. | 34.51 Million USD | 703.164% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4963.645% |
| Bicycle Therapeutics plc | -481.46 Million USD | 56.765% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 675.627% |
| ChromaDex Corporation | -24.04 Million USD | -765.619% |
| Chimerix, Inc. | -25.51 Million USD | -715.786% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3087.396% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -779.182% |
| CRISPR Therapeutics AG | -150.84 Million USD | -37.999% |
| Precision BioSciences, Inc. | -85.41 Million USD | -143.723% |
| Dyadic International, Inc. | -6.37 Million USD | -3163.731% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1206.496% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2815.773% |
| Lantern Pharma Inc. | -21.7 Million USD | -859.136% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -88.321% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2336.611% |
| Incyte Corporation | -3.17 Billion USD | 93.444% |
| IO Biotech, Inc. | -140.69 Million USD | -47.95% |
| Jaguar Health, Inc. | 29.39 Million USD | 808.258% |
| Novavax, Inc. | -298.29 Million USD | 30.215% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4000.393% |
| Opthea Limited | 28.15 Million USD | 839.286% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1139.883% |
| ContextLogic Inc. | -232 Million USD | 10.274% |
| MiMedx Group, Inc. | -33.9 Million USD | -514.035% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2141.824% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8884.099% |
| NextCure, Inc. | -6.47 Million USD | -3113.895% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -312.198% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3163.27% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1811.415% |
| Vaxcyte, Inc. | -368.22 Million USD | 43.469% |
| PDS Biotechnology Corporation | -32.7 Million USD | -536.414% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1304.792% |
| Pharming Group N.V. | 109.8 Million USD | 289.578% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1096.62% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -18.795% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1024.004% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1024.004% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2831.887% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3452.287% |
| Acelyrin, Inc. | -216.9 Million USD | 4.029% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3610.412% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11974.478% |
| Summit Therapeutics Inc. | 34.67 Million USD | 700.346% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2959.885% |
| Senti Biosciences, Inc. | 1.74 Million USD | 12063.448% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -12.761% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -168.769% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3333.916% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 208745.972% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 33247.134% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -77.848% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -23.736% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 287.755% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2640.442% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -61.225% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3119.233% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 14.111% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1088.843% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 34.272% |
| MEI Pharma, Inc. | -3.7 Million USD | -5518.462% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1763.848% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 228.701% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 848.98% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2815.773% |
| Precigen, Inc. | -481 Thousand USD | -43177.339% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1578.333% |
| AlloVir, Inc. | -62.69 Million USD | -232.042% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -274.301% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 437.567% |
| ImmuCell Corporation | 10.99 Million USD | 1994.025% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -35.043% |
| Onconetix, Inc. | 5.33 Million USD | 4004.463% |
| PureTech Health plc | -167.19 Million USD | -24.502% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -583.401% |
| Elevation Oncology, Inc. | -19.11 Million USD | -988.838% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4140.456% |
| Seer, Inc. | -4.24 Million USD | -4809.528% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -766.015% |
| Innoviva, Inc. | 255.56 Million USD | 181.453% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -272.626% |
| ESSA Pharma Inc. | -33.62 Million USD | -519.138% |
| GlycoMimetics, Inc. | -40.98 Million USD | -407.91% |
| GT Biopharma, Inc. | -1.02 Million USD | -20288.247% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -207.104% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 439.821% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -55.255% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1402.338% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -620.989% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -276221.448% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -574.499% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2440.179% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6552.694% |
| Soligenix, Inc. | -4.95 Million USD | -4103.977% |
| Century Therapeutics, Inc. | 847 Thousand USD | 24676.623% |
| Kura Oncology, Inc. | -20.11 Million USD | -934.715% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -408.635% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2378.733% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 11526.94% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6411.229% |
| Autolus Therapeutics plc | -186.59 Million USD | -11.557% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -322.205% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 24.522% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 707.459% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 226.645% |
| GRI Bio, Inc. | -1.79 Million USD | -11503.344% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2217.299% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -525.925% |
| IGM Biosciences, Inc. | -72.6 Million USD | -186.704% |
| INmune Bio, Inc. | -25.41 Million USD | -719.189% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 237.902% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -310.912% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1181.059% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -7115.575% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 647.584% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -405.436% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 752.859% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 155.077% |
| Verastem, Inc. | -37.27 Million USD | -458.41% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2194.324% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -301.381% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1275.382% |
| Histogen Inc. | -7.48 Million USD | -2680.339% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -863.418% |
| Surrozen, Inc. | -32.66 Million USD | -537.289% |
| Organovo Holdings, Inc. | -1.5 Million USD | -13713.139% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4852.173% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1197.899% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 8057.339% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5108.758% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2383.716% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -379.177% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1328.044% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 34.289% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -28729.183% |
| Apollomics, Inc. | -27.39 Million USD | -659.861% |
| Amarin Corporation plc | -191.04 Million USD | -8.964% |
| Mesoblast Limited | 55.96 Million USD | 471.967% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1327.345% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -723.043% |
| Synaptogenix, Inc. | -28.66 Million USD | -626.284% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -22139.744% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 527.161% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -24046.463% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2764.873% |
| Exelixis, Inc. | -73.05 Million USD | -184.961% |
| Better Therapeutics, Inc. | -860 Thousand USD | -24105.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -766.88% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 13.758% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 28380.616% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2698.605% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 16700.0% |
| Gritstone bio, Inc. | 39.49 Million USD | 627.131% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -147.517% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7808.546% |
| Avid Bioservices, Inc. | 169.72 Million USD | 222.646% |
| Insmed Incorporated | 721.62 Million USD | 128.847% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2177.129% |
| MediWound Ltd. | -5.32 Million USD | -3811.387% |
| OmniAb, Inc. | 9.2 Million USD | 2361.915% |
| Alector, Inc. | -35.63 Million USD | -484.123% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 342.133% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4124.107% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1672.354% |
| Zai Lab Limited | -775 Million USD | 73.14% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 161.125% |
| Aura Biosciences, Inc. | -21.52 Million USD | -867.08% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -152.381% |
| Immunic, Inc. | -45.34 Million USD | -359.118% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -7.737% |
| Veracyte, Inc. | -203.82 Million USD | -2.129% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 132.613% |
| FibroGen, Inc. | 56.76 Million USD | 466.699% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2437.608% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -7263.211% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9954.542% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.535% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6130.59% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -25.427% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1265.401% |
| Galecto, Inc. | -21.21 Million USD | -881.165% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -775.19% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 113.264% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -750.621% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1709.021% |
| XBiotech Inc. | -200.02 Million USD | -4.07% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -147.517% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4697.261% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -490.318% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -169.58% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3757.775% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -22.151% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -125.349% |
| Vaxxinity, Inc. | 10.13 Million USD | 2154.52% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 128.273% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1833.253% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -215.61% |
| NexImmune, Inc. | -3.13 Million USD | -6542.875% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5929.068% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1277.525% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -668.133% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2219.104% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -166999.338% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -413.073% |
| Ainos, Inc. | 4.07 Million USD | 5204.651% |
| Pluri Inc. | 22.82 Million USD | 1011.84% |
| Prothena Corporation plc | -608.34 Million USD | 65.782% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -75.287% |
| Celularity Inc. | 65.19 Million USD | 419.319% |
| Rallybio Corporation | -24.1 Million USD | -763.679% |
| Cue Biopharma, Inc. | -33.81 Million USD | -515.524% |
| MeiraGTx Holdings plc | -40.3 Million USD | -416.51% |
| Omeros Corporation | 331.17 Million USD | 162.856% |
| Humacyte, Inc. | -22.48 Million USD | -825.749% |
| Immunocore Holdings plc | -358.59 Million USD | 41.95% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -747.056% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -573.648% |
| Blueprint Medicines Corporation | 702.83 Million USD | 129.618% |
| CalciMedica, Inc. | -5.53 Million USD | -3664.268% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -10.596% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1938.026% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -419.929% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -526.001% |
| Pulmatrix, Inc. | -10.41 Million USD | -1898.31% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3382.751% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -445.761% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -86.858% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -247.264% |
| Cytokinetics, Incorporated | 642.37 Million USD | 132.406% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3474.858% |
| Nutriband Inc. | -251.65 Thousand USD | -82617.349% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -510.112% |
| Vor Biopharma Inc. | 4.3 Million USD | 4941.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.551% |
| Evogene Ltd. | -19.63 Million USD | -960.222% |
| ProKidney Corp. | -56.23 Million USD | -270.161% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -327.687% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2153.543% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 115.262% |
| CorMedix Inc. | -43.05 Million USD | -383.512% |
| BioLineRx Ltd. | 7.33 Million USD | 2937.568% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -657.925% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 551.089% |
| Atai Life Sciences N.V. | -28.55 Million USD | -628.917% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9432.495% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -812.36% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1273.747% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -177.278% |
| MediciNova, Inc. | -50.78 Million USD | -309.905% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -164.151% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -925278.973% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3126.054% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -4.175% |
| Biomea Fusion, Inc. | -166.57 Million USD | -24.971% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -16.309% |
| Mereo BioPharma Group plc | -51.46 Million USD | -304.445% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -119.48% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 29.138% |
| Absci Corporation | -72.59 Million USD | -186.735% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4659.001% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 11.207% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -120.955% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -117.526% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -432.757% |
| Allakos Inc. | -24.97 Million USD | -733.489% |
| Imunon, Inc. | -4.21 Million USD | -4839.993% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1312.047% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -53.74% |
| BioAtla, Inc. | -109.01 Million USD | -90.957% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 28380.616% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -22068.69% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1839.629% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -881.767% |
| XOMA Corporation | -29 Million USD | -617.807% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1157.029% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2208.829% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2694.523% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -67.018% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -154.545% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -124.404% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -24128.105% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5313.888% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12926.747% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 115.075% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -17420.231% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4840.697% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 283.435% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 289369.337% |
| Orgenesis Inc. | 21.78 Million USD | 1055.582% |
| Entera Bio Ltd. | -10.62 Million USD | -1858.453% |
| GH Research PLC | -78.07 Million USD | -166.614% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -833.973% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -680.839% |
| Xencor, Inc. | 29.64 Million USD | 802.213% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -10467.709% |
| Replimune Group, Inc. | 1.41 Million USD | 14842.493% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -84896.815% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -64.665% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -17420.231% |
| Portage Biotech Inc. | -4.98 Million USD | -4079.161% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -925278.973% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -214.818% |
| OncoCyte Corporation | -6.56 Million USD | -3071.781% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 23296.009% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4469.366% |
| Purple Biotech Ltd. | -14.13 Million USD | -1372.372% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -776.259% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3080.504% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1147.076% |
| HilleVax, Inc. | -165.48 Million USD | -25.79% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -8101.891% |
| Tharimmune, Inc. | -10.93 Million USD | -1803.588% |
| Genprex, Inc. | -6.73 Million USD | -2989.573% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 43.557% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -135.32% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -14758.244% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6175.773% |
| OKYO Pharma Limited | -826.84 Thousand USD | -25075.607% |
| Savara Inc. | 153 Thousand USD | 136154.902% |
| Curis, Inc. | -23.88 Million USD | -771.453% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3935.82% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -26724.843% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3253.157% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 17666.582% |
| BeiGene, Ltd. | -2.25 Billion USD | 90.761% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1787.109% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 65.774% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -12.166% |
| Erasca, Inc. | -37.21 Million USD | -459.34% |
| bluebird bio, Inc. | 108.57 Million USD | 291.731% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -16063.144% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 154.961% |
| DBV Technologies S.A. | -126.98 Million USD | -63.927% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -16063.144% |
| Moderna, Inc. | -2.9 Billion USD | 92.839% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1910.858% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1815.385% |
| Molecular Templates, Inc. | 707 Thousand USD | 29543.281% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -563.556% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 160.057% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -153.667% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -126.931% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -545.03% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -505.55% |
| MacroGenics, Inc. | -66.98 Million USD | -210.762% |
| RenovoRx, Inc. | -1.17 Million USD | -17646.292% |
| Adicet Bio, Inc. | -138.78 Million USD | -49.988% |
| Prime Medicine, Inc. | -27.94 Million USD | -645.013% |
| Aditxt, Inc. | 18.12 Million USD | 1248.752% |
| Adagene Inc. | -87.62 Million USD | -137.556% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4897.422% |
| Quantum-Si incorporated | -118.55 Million USD | -75.581% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 678.153% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2685.105% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -329.124% |
| SciSparc Ltd. | -2.06 Million USD | -9980.581% |
| Vericel Corporation | 1.27 Million USD | 16401.018% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1635.901% |
| Minerva Neurosciences, Inc. | 41 Million USD | 607.664% |
| Generation Bio Co. | 31.44 Million USD | 761.931% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -18.704% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -573.169% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 278.539% |
| Invivyd, Inc. | -198.47 Million USD | -4.881% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -130.602% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8581.863% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -194.058% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2950.022% |
| 2seventy bio, Inc. | 181.71 Million USD | 214.555% |
| ADMA Biologics, Inc. | 90.06 Million USD | 331.124% |
| Clene Inc. | 3.34 Million USD | 6332.455% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2191.873% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -867.71% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3126.054% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 39.509% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -700.641% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 217.166% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4987.635% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4261.615% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3896.237% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -59.753% |
| Evaxion Biotech A/S | 5.28 Million USD | 4037.396% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -84.923% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -58.573% |
| Trevena, Inc. | 2.25 Million USD | 9318.955% |
| Surrozen, Inc. | -32.66 Million USD | -537.289% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -304.123% |
| Cingulate Inc. | 3.08 Million USD | 6852.689% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6987.64% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2996.396% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2140.436% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -162.426% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -58.357% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -97.233% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5179.817% |
| Kronos Bio, Inc. | -36.05 Million USD | -477.367% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2312.392% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14376.123% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -283.67% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1543.938% |
| ImmunityBio, Inc. | 618.22 Million USD | 133.671% |
| Korro Bio, Inc. | -132.94 Million USD | -56.581% |
| Kineta, Inc. | -4.54 Million USD | -4484.1% |
| BioVie Inc. | -17.73 Million USD | -1073.922% |
| Codexis, Inc. | -43.27 Million USD | -381.07% |
| Celularity Inc. | 65.19 Million USD | 419.319% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6468.76% |
| Celcuity Inc. | 6.78 Million USD | 3168.677% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6086.255% |
| Cibus, Inc. | -8.07 Million USD | -2476.925% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4822.298% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4655.011% |
| IN8bio, Inc. | -16.38 Million USD | -1170.145% |
| Kodiak Sciences Inc. | -103.87 Million USD | -100.399% |
| Annexon, Inc. | -193.75 Million USD | -7.437% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 578333.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1089.577% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5825.534% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 119.745% |
| Eyenovia, Inc. | 1.25 Million USD | 16637.989% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 873.7% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6318.871% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -526.114% |
| Arcellx, Inc. | -296.95 Million USD | 29.901% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -967.179% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -253.569% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -904.313% |
| Moolec Science SA | 117.61 Thousand USD | 177086.124% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -442.108% |
| Geron Corporation | 14.76 Million USD | 1510.23% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -448.985% |
| Royalty Pharma plc | 5.65 Billion USD | 103.679% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -47.195% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2878.271% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3781.586% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -47.916% |
| Humacyte, Inc. | -22.48 Million USD | -825.749% |
| Structure Therapeutics Inc. | -124.33 Million USD | -67.416% |
| 89bio, Inc. | -289.05 Million USD | 27.984% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -724.673% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -11574.93% |
| Genelux Corporation | -6.89 Million USD | -2917.307% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -570.221% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 349.003% |
| Notable Labs, Ltd. | -9.77 Million USD | -2029.337% |
| Liquidia Corporation | -80.17 Million USD | -159.634% |
| Mustang Bio, Inc. | -3.73 Million USD | -5471.842% |
| Immunovant, Inc. | -635.22 Million USD | 67.23% |
| Quantum-Si incorporated | -118.55 Million USD | -75.581% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1085.174% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4924.475% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2693.298% |
| Acasti Pharma Inc. | -23 Million USD | -804.864% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6082.057% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1181.059% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -51.128% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6579.712% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -836.326% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1021.03% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -22.972% |
| PepGen Inc. | -60.67 Million USD | -243.109% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -806.006% |
| United Therapeutics Corporation | -507.7 Million USD | 58.999% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -988.382% |
| Solid Biosciences Inc. | -47.75 Million USD | -335.946% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -24046.463% |
| Immuneering Corporation | -54.94 Million USD | -278.874% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4852.173% |
| Silo Pharma, Inc. | -3.52 Million USD | -5806.521% |
| Belite Bio, Inc | -87.27 Million USD | -138.526% |
| XOMA Corporation | -29 Million USD | -617.807% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -194.445% |
| Bionomics Limited | 227 Million USD | 191.698% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -79.017% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8118.081% |
| uniQure N.V. | -102.95 Million USD | -102.197% |
| Cassava Sciences, Inc. | -121.13 Million USD | -71.843% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4897.422% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 608.325% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1640.356% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6627.555% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 196481.132% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6318.871% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2437.608% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2706.958% |
| Altimmune, Inc. | -134.48 Million USD | -54.784% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 205.099% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8118.081% |
| Compugen Ltd. | -12.9 Million USD | -1513.174% |
| Peak Bio, Inc. | 10.34 Million USD | 2113.161% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -73456.184% |
| Benitec Biopharma Inc. | -50.58 Million USD | -311.538% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -99.509% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1159.628% |
| Zura Bio Limited | -99.8 Million USD | -108.569% |
| PolyPid Ltd. | 6.17 Million USD | 3473.809% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 380.847% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1159.628% |
| Instil Bio, Inc. | 75.35 Million USD | 376.233% |
| argenx SE | -2.02 Billion USD | 89.74% |
| Immunome, Inc. | -97.02 Million USD | -114.538% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -825.379% |
| Verona Pharma plc | -220.44 Million USD | 5.57% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -190.152% |
| Shattuck Labs, Inc. | -121.42 Million USD | -71.436% |
| CervoMed Inc. | -7.79 Million USD | -2571.219% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -12.218% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4660.21% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -58.011% |
| Moolec Science SA | 117.61 Thousand USD | 177086.124% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8998.168% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1409.341% |
| AnaptysBio, Inc. | -18.15 Million USD | -1046.846% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1046.909% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -195.767% |
| NeurAxis, Inc. | 145.7 Thousand USD | 142971.654% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1953.312% |
| Lumos Pharma, Inc. | -28.49 Million USD | -630.579% |
| Achilles Therapeutics plc | -126.92 Million USD | -64.007% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -190.152% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -31645.383% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -902.049% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14376.123% |
| Nutriband Inc. | -251.65 Thousand USD | -82617.349% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1480.472% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2697.903% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 161.189% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 977.034% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 53.48% |
| Palisade Bio, Inc. | -12.06 Million USD | -1625.64% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -48.359% |
| Beam Therapeutics Inc. | -262.72 Million USD | 20.766% |
| Neurogene Inc. | -131.95 Million USD | -57.754% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1054.18% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4165.656% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 44.812% |
| Sesen Bio, Inc. | -112.55 Million USD | -84.948% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -108.456% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8766.369% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -433.398% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -149.951% |
| Athira Pharma, Inc. | -88.99 Million USD | -133.895% |
| Vaccinex, Inc. | -1.28 Million USD | -16061.801% |
| HCW Biologics Inc. | 2.85 Million USD | 7386.931% |
| XOMA Corporation | -29 Million USD | -617.807% |
| Nektar Therapeutics | 210.24 Million USD | 199.013% |
| Arvinas, Inc. | -313.8 Million USD | 33.663% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12926.747% |
| Merus N.V. | -192.88 Million USD | -7.922% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 447.027% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2900.346% |
| Rezolute, Inc. | -68.16 Million USD | -205.369% |
| Clene Inc. | 3.34 Million USD | 6332.455% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1478.555% |
| BeyondSpring Inc. | -13.75 Million USD | -1413.37% |
| Synlogic, Inc. | -6.68 Million USD | -3013.897% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 18456.614% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2362.022% |
| Peak Bio, Inc. | 10.34 Million USD | 2113.161% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -152.565% |
| Krystal Biotech, Inc. | -350.23 Million USD | 40.564% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 267.705% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -23.177% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6493.427% |
| MannKind Corporation | 143.89 Million USD | 244.66% |
| Ikena Oncology, Inc. | -109.15 Million USD | -90.703% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2649.491% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -528.894% |
| Gossamer Bio, Inc. | 180.35 Million USD | 215.419% |
| CohBar, Inc. | -5.93 Million USD | -3409.921% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -599.758% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4659.001% |
| Legend Biotech Corporation | -949.39 Million USD | 78.074% |
| Mural Oncology plc | -255.84 Million USD | 18.636% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 746.171% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4319.015% |
| Disc Medicine, Inc. | -358.28 Million USD | 41.899% |
| Champions Oncology, Inc. | 4.81 Million USD | 4425.935% |
| REGENXBIO Inc. | 54.76 Million USD | 480.083% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -77311.15% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -37.835% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2209.852% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -158.002% |
| Vaxart, Inc. | -8.24 Million USD | -2425.956% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -314.835% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -63.695% |
| Cellectis S.A. | -43.85 Million USD | -374.664% |
| Longeveron Inc. | -2.9 Million USD | -7058.322% |
| Repare Therapeutics Inc. | -107.85 Million USD | -92.998% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 121.496% |
| Inozyme Pharma, Inc. | 12 Million USD | 1834.122% |
| Revolution Medicines, Inc. | -608.2 Million USD | 65.774% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -16823.902% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 21.482% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -38.709% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1230.376% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -28030.27% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.823% |
| Denali Therapeutics Inc. | -74.86 Million USD | -178.052% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1635.901% |
| Veru Inc. | 4.77 Million USD | 4454.924% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1751.005% |
| Cingulate Inc. | 3.08 Million USD | 6852.689% |
| Passage Bio, Inc. | 4.58 Million USD | 4640.109% |
| Context Therapeutics Inc. | -14.44 Million USD | -1340.599% |
| Exicure, Inc. | 5.84 Million USD | 3658.967% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 9.642% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -426.065% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1426.646% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -253.894% |
| Nuvalent, Inc. | -335.38 Million USD | 37.933% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 12102.484% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -179.482% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2241.552% |
| OmniAb, Inc. | 9.2 Million USD | 2361.915% |
| Anew Medical, Inc. | 1.43 Million USD | 14631.873% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1370.706% |
| Lipocine Inc. | -4.75 Million USD | -4278.167% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -89.536% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1466.713% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -310.912% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 936.269% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2997.218% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -216.229% |
| Ocugen, Inc. | -32.52 Million USD | -540.091% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -143.253% |
| Q32 Bio Inc. | -37.94 Million USD | -448.551% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -33047.134% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1438.65% |
| Equillium, Inc. | -22.39 Million USD | -829.636% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -714.158% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -538.016% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -83865.875% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 255.298% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6609.193% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 63479.42% |
| Dominari Holdings Inc. | 195 Thousand USD | 106850.769% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3852.298% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2234.462% |
| Bio-Techne Corporation | 267.74 Million USD | 177.747% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1184.249% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -76.27% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2377.258% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1545.435% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 15.076% |
| Nkarta, Inc. | 57.29 Million USD | 463.294% |
| BioCardia, Inc. | 212 Thousand USD | 98290.566% |
| Iterum Therapeutics plc | 13.43 Million USD | 1649.07% |